Armistice Capital’s IceCure Medical ICCM Stock Holding History

Armistice Capital’s Portfolio ICCM Stock Details ICCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-90,400	Closed	-$816K	–	370
2026 Q1	$816K	Buy	+90,400	New	+$1.65M	0.01%	168

Other funds holding ICCM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

SRL

Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GCM

Gunderson Capital Management Mt. Pleasant, South Carolina $370M AUM 211.56% 1-Year Est. Return

KFG

Kingdom Financial Group Peoria, Arizona $391M AUM 21.78% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Armistice Capital's ICCM Position: Q2 2026 in Review

Armistice Capital sold out of IceCure Medical (ICCM) in Q2 2026, closing a stake of 90,400 shares — an estimated $816K sold.

Armistice Capital first reported a position in ICCM in Q1 2026 and held it in 1 quarter. The position peaked at $816K in Q1 2026. 11 funds tracked by Wall St. Rank hold ICCM as of Q2 2026.

Armistice Capital reported no remaining IceCure Medical position as of Q2 2026 after selling out during the quarter.
Armistice Capital sold 90,400 IceCure Medical shares in Q2 2026, an estimated $816K.
Armistice Capital first reported a position in IceCure Medical in Q1 2026 and held it in 1 quarter.
Armistice Capital's IceCure Medical position peaked at $816K in Q1 2026.
11 funds tracked by Wall St. Rank held IceCure Medical as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.